Inequality in the United States has never been more apparent, especially…
According to the Centers for Disease Control and Prevention (CDC), the…
Although a new injectable anti-HIV drug, cabotegravir, could be instrumental in…
Mark Cuban is spearheading an effort to widen Americans’ access to…
Medicare recently announced that its Part B outpatient premium will increase…
Prescription drug costs continue to be a concern for many Americans….
According to the World Health Organization, cardiovascular disease is the leading…
Entrepreneur Nutte Van Belzen of CC Diagnostics recently won the 2019…
Suitable animal models are an unavoidable necessity in the testing and…
As a pioneer with the Standard for Exchange Nonclinical Data (SEND)…
Wish I May is a volunteer-run 501(c)(3) non-profit organization in the Springfield,…
Did you know that 23.6 percent of the world’s pharmaceutical companies…
Two power women currently ‘man’ the Business Development (BD) department at…
Later this month the United Kingdom (UK) is expected to achieve…
For outstanding performance including growth in sales, continuous growth in minority…
Mr. Sanjay Mitter joined QPS as VP and Global Head of…
Since 2012, a New Investigator Award has been given annually to…
QPS CEO Ben Chien has made it through to the round…
Executive Summary Biosimilars have advanced from a promising idea to a proven pathway for expanding patient access to biologic therapies and easing pressure on…
Introduction Real-world evidence (RWE) is accelerating drug development by using routinely collected patient health data, known as real-world data (RWD), to deliver insights beyond…
Introduction Researchers are developing novel, safer treatments for cancer, but bringing new oncology therapies to market is challenging. This white paper will examine the…
NEWARK, Del.–(BUSINESS WIRE)–QPS Holdings, LLC (QPS), an award-winning contract research organization (CRO) focused on bioanalysis and clinical trials announces the successful implementation of Oracle…
NEWARK, Del.—(BUSINESS WIRE)—QPS Holdings, LLC (QPS), an award-winning contract research organization (CRO) focused on bioanalytics and clinical trials, is celebrating its 30-year anniversary in…
NEWARK, Del.—(BUSINESS WIRE)—QPS India, a subsidiary of QPS Holdings, LLC (QPS), a GLP/GCP-compliant global full-service Contract Research Organization, has achieved another significant milestone by…
Webinars
QPS and Bioanalysis Zone: Advancing Bioanalytical Method Development and Validation for Small Molecules in a Changing Regulatory Landscape
Click here to watch the webinar.
QPS and Bioanalysis Zone: Advancing Bioanalytical Method Development and Validation for Small Molecules in a Changing Regulatory Landscape
Click here to watch the webinar.

Burden of Disease by Social Status
September 28, 2022
Inequality in the United States has never been more apparent, especially in the wake of the COVID-19 pandemic. In a time when higher income correlates

More Simple Rabies Test Could Reduce Rabies Deaths
September 21, 2022
According to the Centers for Disease Control and Prevention (CDC), the rabies virus leads to an estimated 59,000 human deaths globally each year. This deadly

Holding Out Hope for a Deal on Long-Lasting HIV Prevention Drug
September 11, 2022
Although a new injectable anti-HIV drug, cabotegravir, could be instrumental in drastically reducing the spread of disease, its price tag may render the drug unattainable

From Shark Tank to Pharmaceuticals: Billionaire Mark Cuban Makes a Leap for Affordable Medicines
April 4, 2022
Mark Cuban is spearheading an effort to widen Americans’ access to generic pharmaceuticals, adding a direct-to-consumer online pharmacy to the Mark Cuban Cost Plus Drug

Sea Squirts and Missing Genes
February 2, 2022
It might seem odd to use a tiny sea creature to explore human genetics. However, as recently reported on Shamini Bundell’s Nature Podcast, marine organisms

Medicare: Rising Premiums and Novel AD Drugs
January 12, 2022
Medicare recently announced that its Part B outpatient premium will increase by $21.60 per month in 2022. The increase marks one of Medicare’s largest premium

How Congress Could Regulate Medicare Drug Prices
December 1, 2021
Prescription drug costs continue to be a concern for many Americans. But now, as Congress works to finalize President Biden’s Build Back Better social spending

Aiding in the Development of Cardiovascular Drugs
January 13, 2020
According to the World Health Organization, cardiovascular disease is the leading cause of death in the United States and worldwide. In fact, about 17.9 million

QPS Physician Nutte Van Belzen Wins 2019 Young Entrepreneur Award
December 20, 2019
Entrepreneur Nutte Van Belzen of CC Diagnostics recently won the 2019 Jonge Ondernemingsprijs (Young Entrepreneur Award). Van Belzen also happens to work as a part-time
Establishing Preclinical Leadership in Asia with the Addition of Mini Pig Studies
August 19, 2019
Suitable animal models are an unavoidable necessity in the testing and development of new pharmacological agents. QPS has an extensive history of conducting studies in
Establishing Leadership in Asia with SEND
August 12, 2019
As a pioneer with the Standard for Exchange Nonclinical Data (SEND) system in Asia, QPS Taiwan CTPS has taken a leadership role in implementing and
QPS Missouri Collaborates with Local Agency to Bring Birthday Celebrations to Underserved Children
August 8, 2019
Wish I May is a volunteer-run 501(c)(3) non-profit organization in the Springfield, Missouri, community striving to make a difference one child and one birthday at a
QPS Celebrating Sustained Growth in Asia
June 24, 2019
Did you know that 23.6 percent of the world’s pharmaceutical companies are now located in Asia? That’s up from 20.5 percent in 2018 – a
Power Women in Business Development at QPS Netherlands
June 13, 2019
Two power women currently ‘man’ the Business Development (BD) department at QPS Netherlands, in close collaboration with the Head of BD, Edwin van Vulpen, MBA,
QPS: Young at Heart
May 9, 2019
At QPS, we work with a team of Research Physicians, who are all young professionals pursuing a career in Drug Development and/or Clinical Pharmacology. For

BREXIT IMPACT: More Questions Than Answers
March 30, 2019
Later this month the United Kingdom (UK) is expected to achieve independence from the European Union (EU) based on a referendum that was passed in
QPS Is Eastern Minority Supplier Development Council (EMSDC) 2016 Class IV Supplier of the Year
December 5, 2016
For outstanding performance including growth in sales, continuous growth in minority business to minority business purchases, innovation in the delivery of services, significant and continuous
Sanjay Mitter new VP and Global Head of Clinical Research Services
September 14, 2016
Mr. Sanjay Mitter joined QPS as VP and Global Head of Clinical Research Services. He is currently responsible for Clinical Research, i.e. global pharmacokinetics, data

QPS Netherlands scientist Daniel Wilffert nominated for New Investigator Award by Bioanalysis Zone!
June 22, 2016
Since 2012, a New Investigator Award has been given annually to honor excellence among bioanalytical scientists within their first five years in the industry. In
Ben Chien is an EY Entrepreneur Of The Year® 2016 Finalist for Greater Philadelphia!
May 17, 2016
QPS CEO Ben Chien has made it through to the round of 30 (31, actually) being considered for this year’s prestigious EY Entrepreneur Of The
Executive Summary Biosimilars have advanced from a promising idea to a proven pathway for expanding patient access to biologic therapies and easing pressure on…
Introduction Real-world evidence (RWE) is accelerating drug development by using routinely collected patient health data, known as real-world data (RWD), to deliver insights beyond…
Introduction Researchers are developing novel, safer treatments for cancer, but bringing new oncology therapies to market is challenging. This white paper will examine the…
NEWARK, Del.–(BUSINESS WIRE)–QPS Holdings, LLC (QPS), an award-winning contract research organization (CRO) focused on bioanalysis and clinical trials announces the successful implementation of Oracle…
NEWARK, Del.—(BUSINESS WIRE)—QPS Holdings, LLC (QPS), an award-winning contract research organization (CRO) focused on bioanalytics and clinical trials, is celebrating its 30-year anniversary in…
NEWARK, Del.—(BUSINESS WIRE)—QPS India, a subsidiary of QPS Holdings, LLC (QPS), a GLP/GCP-compliant global full-service Contract Research Organization, has achieved another significant milestone by…